The company has landed a lucrative flu-vaccine contract with the U.S. government. It’s worth $97 million over the first three years, and it can be extended for an additional two years, for a total contract value of $179.1 million. The technology could prove to be a lifesaver.
Continue reading Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine
Novavax Gets a Federal Grant for Developing Its Novel Flu Vaccine originally appeared on DailyFinance on Tue, 01 Mar 2011 15:30:00.
Filed Under: Company News, Technology, Columns, Investing, Health Care, Stocks in the News